CEO of Project Foundry
Vice President for Research at UT Health Science Center at San Antonio
Professor of Systems Biology, Columbia University
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Washington state has some of the world’s top companies developing targeted antibody drugs. Speakers from Seattle Genetics, Alder Biopharmaceuticals, VLST, Arch Venture Partners, Theraclone Sciences, Omeros and more will be on hand for an “antibody hub” summit organized by the WBBA on April 10. For more information on how to register, click here.